Group photo of the Asnani Lab

Asnani Lab

We seek to understand the molecular pathways leading to heart dysfunction in patients treated for cancer.

 

Who we are

Some of the most successful cancer treatments have toxic effects on the heart. We use zebrafish and mouse models, coupled with studies in patients, to define the molecular pathways that drive heart dysfunction in patients treated for cancer.
Our goal is to develop new ways to protect the heart during cancer therapy. What we learn from cancer drugs may help us understand how heart disease arises in patients without cancer.

Featured Research Areas

CYP1 inhibition protects against anthracycline-induced cardiac toxicity

Heme signaling and immune mechanisms in cardiomyopathy

Improving cardiac risk stratification in patients receiving anthracyclines

Woman in a hospital bed doing chemotherapy

 

Our Latest Updates


 

 

The Asnani Lab is located at

 

Beth Israel Deaconess Medical Center